Neurodegenerative Langerhans cell histiocytosis: building the evidence for prospective monitoring and early treatment. Response to Comment on: “Neurodegenerative Langerhans cell histiocytosis: longterm follow-up of 63 patients from the Italian Registry”

Francesco Pegoraro; Irene Trambusti; Elena Sieni

doi:10.3324/haematol.2026.301539

Comments

Neurodegenerative Langerhans cell histiocytosis: building the evidence for prospective monitoring and early treatment. Response to Comment on: “Neurodegenerative Langerhans cell histiocytosis: longterm follow-up of 63 patients from the Italian Registry”

Francesco Pegoraro
Irene Trambusti
Elena Sieni

Department of Hematology and Oncology, Meyer Children’s Hospital IRCCS, Firenze, Italy; Department of Experimental and Clinical Medicine, University of Firenze, Firenze

Department of Hematology and Oncology, Meyer Children’s Hospital IRCCS, Firenze

Haematologica Early view Jul 16, 2026 https://doi.org/10.3324/haematol.2026.301539

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments

DOI

https://doi.org/10.3324/haematol.2026.301539

Published

2026-07-16

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

Copyright & Usage

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

97

PDF Downloads

50

No Data

PlumX

Neurodegenerative Langerhans cell histiocytosis: building the evidence for prospective monitoring and early treatment. Response to Comment on: “Neurodegenerative Langerhans cell histiocytosis: longterm follow-up of 63 patients from the Italian Registry”

Abstract

Figures & Tables

Article Information

Article Usage

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More